IPR And CBM Statistics For Final Written Decisions Issued In February 2016

FH
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Contributor

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is a law firm dedicated to advancing ideas, discoveries, and innovations that drive businesses around the world. From offices in the United States, Europe, and Asia, Finnegan works with leading innovators to protect, advocate, and leverage their most important intellectual property (IP) assets.
In the 35 Final Written Decisions issued by the Patent Trial and Appeal Board in February, the Board cancelled 491 (79.45%) of the instituted claims and declined to cancel 112 (18.12%) of the instituted claims.
United States Intellectual Property

In the 35 Final Written Decisions issued by the Patent Trial and Appeal Board in February, the Board cancelled 491 (79.45%) of the instituted claims and declined to cancel 112 (18.12%) of the instituted claims. Patent owners conceded 15 (2.43%) of the instituted claims through motions to amend or disclaimer.

On a per-case basis, no instituted or substitute claims survived in 29 (82.86%) of the decisions, all instituted claims survived in 2 (5.71%) of the decisions, and a mixed outcome occurred in 4 (11.43%) of the decisions. A mixed outcome occurs where at least one instituted or substitute claim remains patentable, and at least one is cancelled, in a Final Written Decision.

The following resources are also available on the AIA Blog:

Various other PTAB metrics collected and generated by Finnegan are reserved for the use of Finnegan and its clients.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More